Rheumatology
Conference Coverage
EULAR COVID-19 recommendations set for update
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further...
News
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
Patients who take methotrexate or rituximab seem to be especially vulnerable.
News
FDA panel narrowly backs avacopan approval
The FDA is mulling whether to approve avacopan for ANCA-associated vasculitis based largely on a single trial about which the agency staff has...
Conference Coverage
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
Conference Coverage
Multiple studies highlight pandemic’s impact on patients with rheumatic disease
From the Europe-based REUMAVID study to the United Kingdom’s CONTAIN study, some common themes are emerging, with lessons to be learned for future...
Conference Coverage
Challenges persist in adolescents with rheumatic disease transitioning to adult care
A successful transition from pediatric to adult rheumatology is crucial to maintain continuity of care for patients with rheumatic disease, but...
News
Study shows how COVID-19 disrupted RA meds
Early COVID-19 restrictions significantly altered medication and management patterns among RA patients.
News
Self-directed digital exercise plan improves knee OA
Web-based exercises plus automated text messages improved knee pain and function over web-based information without exercises.
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
Conference Coverage
Experts highlight recent breakthroughs in psoriatic arthritis
Signal of possible gender disparity in PsA response to biologics sparks questions.